The results collectively indicate that DNA repair capacity arising from low-penetrance genes, including the XRCC1 polymorphism, may be modified by other genetically determined or environmental risk factors that correlate with response of NPC to radiotherapy. The gene discussed is XRCC1; the disease is nasopharyngeal carcinoma.